Literature DB >> 19727972

Completely laparoscopic subtotal pancreatectomy with splenic artery preservation.

Cherif Boutros1, N Joseph Espat, Ponnandai Somasundar.   

Abstract

INTRODUCTION: Laparoscopic distal pancreatectomy has emerged as an attractive minimally invasive alternative for selected patients. Although technically challenging, distal pancreatectomy with splenic artery preservation has consistently been correlated with reduced blood loss and perioperative morbidity in multiple studies. Herein presented is our technique for completely laparoscopic (non-hand-assisted) subtotal pancreatectomy with splenic artery preservation (LSP-SAP).
METHODS: An 87-year-old woman with an incidentally identified 3-cm cystic lesion in the pancreatic body-tail interface underwent EUS, which supported side-branch intraductal papillary mucinous neoplasm. The patient subsequently underwent laparoscopic resection. A completely laparoscopic procedure was performed using a four-trochar technique. The tail and body of the pancreas were dissected off of the retroperitoneum along the embryologic plane and separated from the colonic splenic flexure. Next, the splenic artery was dissected, isolated, and preserved, while the splenic vein was dissected off the ventral pancreas up to the level of the splenic-portal vein confluence. The technique employed a bipolar cutter-sealing device for dissection and hemostasis. Pancreatic parenchymal transection was performed with a standard vascular load endomechanical stapling device.
RESULTS: Total procedure time was 210 min, and the estimated blood loss was 200 mL. Postoperatively, the patient was admitted, advanced to regular diet the next day, and discharged home on postoperative day 3. The pathological review of the specimen revealed high-grade dysplasia with a non-invasive malignant component, classified as intraductal carcinoma. Foci of PanIN 1-3 were identified with no high grade dysplasia at the surgical margin. Five lymph nodes were included in the specimen and were negative for malignancy.
CONCLUSION: Completely LSP-SAP can be safely performed in selected patients. This procedure may be an optimal alternative to open surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19727972     DOI: 10.1007/s11605-009-0995-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  14 in total

Review 1.  Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome.

Authors:  B Edwin; T Mala; Ø Mathisen; I Gladhaug; T Buanes; O C Lunde; O Søreide; A Bergan; E Fosse
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

2.  Pancreatic resection in the elderly.

Authors:  Amy M Lightner; Robert E Glasgow; Thomas H Jordan; Alexander D Krassner; Lawrence W Way; Sean J Mulvihill; Kimberly S Kirkwood
Journal:  J Am Coll Surg       Date:  2004-05       Impact factor: 6.113

3.  Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients.

Authors:  Jean-Yves Mabrut; Laureano Fernandez-Cruz; Juan Santiago Azagra; Claudio Bassi; Georges Delvaux; Joseph Weerts; Jean-Michel Fabre; Jean Boulez; Jacques Baulieux; Jean-Louis Peix; Jean-François Gigot
Journal:  Surgery       Date:  2005-06       Impact factor: 3.982

4.  Laparoscopic distal pancreatectomy: the Brisbane experience of forty-six cases.

Authors:  C Taylor; N O'Rourke; L Nathanson; I Martin; G Hopkins; L Layani; M Ghusn; G Fielding
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Laparoscopic surgery combined with preservation of the spleen for distal pancreatic tumors.

Authors:  A Vezakis; D Davides; M Larvin; M J McMahon
Journal:  Surg Endosc       Date:  1999-01       Impact factor: 4.584

6.  Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients.

Authors:  Robert R Hutchins; Richard S Hart; Marc Pacifico; Nicholas J Bradley; Robin C N Williamson
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

7.  Is laparoscopic left pancreatic resection justified?

Authors:  J M Fabre; J L Dulucq; C Vacher; M C Lemoine; P Wintringer; D Nocca; J S Burgel; J Domergue
Journal:  Surg Endosc       Date:  2002-05-03       Impact factor: 4.584

8.  The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma.

Authors:  R E Schwarz; L E Harrison; K C Conlon; D S Klimstra; M F Brennan
Journal:  J Am Coll Surg       Date:  1999-05       Impact factor: 6.113

9.  Distal pancreatectomy: indications and outcomes in 235 patients.

Authors:  K D Lillemoe; S Kaushal; J L Cameron; T A Sohn; H A Pitt; C J Yeo
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

10.  Laparoscopic pancreatic resection: single-institution experience of 19 patients.

Authors:  E J Patterson; M Gagner; B Salky; W B Inabnet; S Brower; M Edye; B Gurland; M Reiner; D Pertsemlides
Journal:  J Am Coll Surg       Date:  2001-09       Impact factor: 6.113

View more
  4 in total

1.  Acinar Cell Cystadenoma of the Pancreas: a Multidisciplinary and Contemporary Approach.

Authors:  Sabrina C Sopha; J H Terhune; L Hoover; L Uradomo; C N Boutros
Journal:  J Gastrointest Surg       Date:  2018-01-29       Impact factor: 3.452

2.  Laparoscopic spleen-preserving distal pancreatectomy in elderly subjects: splenic vessel sacrifice may be associated with a higher rate of splenic infarction.

Authors:  Keith M Baldwin; Steven C Katz; N Joseph Espat; Ponnandai Somasundar
Journal:  HPB (Oxford)       Date:  2011-09       Impact factor: 3.647

3.  Lateral approach in laparoscopic distal pancreatectomy is safe and potentially beneficial compared to the traditional medial approach.

Authors:  Matt Strickland; Julie Hallet; Daniel Abramowitz; Shuyin Liang; Calvin H L Law; Shiva Jayaraman
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

4.  Dual-Incision Laparoscopic Spleen-Preserving Distal Pancreatectomy: Merits Compared to the Conventional Method.

Authors:  Eun Young Kim; Young Kyoung You; Dong Goo Kim; Tae Ho Hong
Journal:  J Gastrointest Surg       Date:  2018-10-26       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.